B Jones

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Weight change and atypical antipsychotic treatment in patients with schizophrenia
    B Jones
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Ind 46285, USA
    J Clin Psychiatry 62:41-4. 2001
  2. ncbi request reprint The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms
    B Jones
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA
    J Clin Psychiatry 62:22-4. 2001

Detail Information

Publications2

  1. ncbi request reprint Weight change and atypical antipsychotic treatment in patients with schizophrenia
    B Jones
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Ind 46285, USA
    J Clin Psychiatry 62:41-4. 2001
    ..Weight gain interventions, including behavioral modifications, show promise in controlling or reducing weight in patients treated with antipsychotics...
  2. ncbi request reprint The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms
    B Jones
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA
    J Clin Psychiatry 62:22-4. 2001
    ..These results suggest that intramuscular olanzapine has positive symptom efficacy early in the course of treatment and may provide a smooth transition to maintenance therapy with oral olanzapine...